Systemic lupus erythematosus following human papillomavirus vaccination: A case‐based review
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic lupus erythematosus following human papillomavirus vaccination: A case‐based review
Authors
Keywords
-
Journal
International Journal of Rheumatic Diseases
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-08-11
DOI
10.1111/1756-185x.14404
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aluminium adjuvants in vaccines – A way to modulate the immune response
- (2021) Ravi Danielsson et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Broad immune activation underlies shared set point signatures for vaccine responsiveness in healthy individuals and disease activity in patients with lupus
- (2020) Yuri Kotliarov et al. NATURE MEDICINE
- Learning from similarities between vaccine responses and SLE
- (2020) Marie Wahren-Herlenius et al. Nature Reviews Rheumatology
- Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with childhood systemic lupus erythematosus: a real-world interventional multi-centre study
- (2020) Ingrid Herta Rotstein Grein et al. LUPUS
- Human papillomavirus vaccine safety in systemic lupus erythematosus patients
- (2020) Paula David et al. LUPUS
- Aluminum in vaccines: Does it create a safety problem?
- (2018) Nicola Principi et al. VACCINE
- Prevalence of cervical HPV infection in women with systemic lupus erythematosus: A systematic review and meta-analysis
- (2018) Mario García-Carrasco et al. AUTOIMMUNITY REVIEWS
- HPV vaccines and lupus: current approaches towards preventing adverse immune cross-reactivity
- (2018) Nicola L. Bragazzi et al. Expert Review of Vaccines
- HPV and systemic lupus erythematosus: a mosaic of potential crossreactions
- (2017) Yahel Segal et al. IMMUNOLOGIC RESEARCH
- Personalized vaccinology: A review
- (2017) G.A. Poland et al. VACCINE
- Evidence Refuting the Existence of Autoimmune/Autoinflammatory Syndrome Induced by Adjuvants (ASIA)
- (2017) Rohan Ameratunga et al. Journal of Allergy and Clinical Immunology-In Practice
- Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case–control assessment of the vaccine adverse event reporting system (VAERS) database
- (2016) David A. Geier et al. IMMUNOLOGIC RESEARCH
- Infections as risk factor for autoimmune diseases – A nationwide study
- (2016) Philip Rising Nielsen et al. JOURNAL OF AUTOIMMUNITY
- Refractory Genital HPV Infection and Adult-Onset Still Disease
- (2016) Xin Yu et al. MEDICINE
- Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases
- (2014) Annette Langer-Gould et al. JAMA Neurology
- Human papillomavirus vaccine and systemic lupus erythematosus
- (2013) Mariele Gatto et al. CLINICAL RHEUMATOLOGY
- Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study
- (2013) L. Arnheim-Dahlstrom et al. BMJ-British Medical Journal
- Systemic lupus erythematosus following HPV immunization or infection?
- (2012) HF Soldevilla et al. LUPUS
- The immunobiology of aluminium adjuvants: how do they really work?
- (2010) Christopher Exley et al. TRENDS IN IMMUNOLOGY
- Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine
- (2009) Barbara A. Slade JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started